Phoenix Meds Inc. provides administrative sourcing coordination for licensed U.S. healthcare organizations. We assist with professional credential verification, documentation, and communication between clinics and independent pharmaceutical sources. Phoenix Meds is not a pharmacy, wholesaler, distributor, or medical practice and does not independently prescribe, manufacture, compound, dispense, or ship medications.
Before evaluating a pharmaceutical source, clinics may need answers about the organizations involved, the information available, and the scope of a supplier’s authorization. Phoenix Meds helps bring these details into focus through an organized approach shaped by industry experience and an understanding of the sourcing process.
A supplier’s license is an important starting point, but it does not establish that every product or transaction is permitted. Clinics must also consider the type of facility involved and the requirements applicable to its activities.
Traditional compounding pharmacies, FDA-registered 503B outsourcing facilities, and pharmaceutical wholesalers operate under different regulatory frameworks. For example, registration as a 503B outsourcing facility does not mean the FDA has approved its compounded drugs or determined that the facility complies with every applicable requirement.
For clinics, a meaningful review looks beyond a registration number. The specific preparation, intended activity, and applicable federal and state requirements all matter when evaluating a potential pharmaceutical source.
Phoenix Meds Inc. was founded by Alfred Lamoureux, who brings more than 20 years of experience in pharmaceutical sourcing and healthcare operations. His industry background shapes our practical approach to working with clinics and independent pharmaceutical organizations. Our Working Principles:
a) Professional Credentials: We assist with requests for relevant licensing information, facility registration details, and supporting records.
b) Organized Follow-Ups: We help track outstanding inquiries and facilitate responses between participating parties.
c) Clear Responsibilities: Clinical decisions, product quality assurance, and regulated fulfillment activities remain with the appropriately authorized organizations.
We support clinics and medical providers in sourcing high-demand peptides and injectable medications across key therapeutic and research domains.
Our network focuses on compounds relevant to:
Product availability and fulfillment eligibility are determined by the independently authorized supplier, subject to applicable federal and state requirements. Phoenix Meds provides administrative coordination and does not guarantee product availability.
Clinics within our network commonly request peptides across a range of research and clinical interest areas, including:
Thymosin Beta-4, BPC-157, KPV, GHK-Cu
AOD-9604, CJC-1295, Ipamorelin, MOTS-C
Semax, Selank, DSIP (Emideltide)
Thymosin Alpha-1, Epitalon, LL-37
GHRP-2, GHRP-6, Kisspeptin-10, PEG-MGF, Melanotan II
These categorizations reflect areas of clinical and research interest and do not imply approved therapeutic indications.
We support the coordination and sourcing of Tesamorelin for clinics and licensed providers operating within approved clinical or investigational frameworks. This compound is commonly referenced in metabolic and endocrine-related research and treatment contexts.
Access is subject to appropriate clinical authorization and jurisdictional requirements.
Providers must submit NPI and state medical licensure for verification. Access to the platform is restricted to licensed clinics and US medical professionals only.
The authorized 503A or 503B pharmacy or an authorized partner processes the order. The medication is then shipped directly to the clinic or patient from the licensed source.
A healthcare supply platform like Phoenix Meds Inc. acts as a facilitator. We do not sell or dispense drugs. We coordinate the data and compliance requirements between your clinic and the pharmacy or distributor.
Compliant medication sourcing in the USA requires rigorous oversight. We reduce the administrative burden on your healthcare staff by centralizing the clinic drug sourcing platform experience.
Phoenix Meds assists licensed healthcare organizations with credential verification, documentation review, and communication with independent pharmaceutical sources. We may review publicly available licensing and regulatory information as part of our administrative process. Each participating organization remains responsible for its own applicable legal and regulatory obligations. Phoenix Meds does not certify or guarantee regulatory compliance.
Yes. Our platform facilitates connections with 503B outsourcing facilities, which are authorized to provide medications for office use and we have 503A pharmacy connections for patient-specific prescriptions.
Yes, you must have a valid State and DEA license to source injectable medications through our partner network. Register to get access to our portal and ordering facility.
503A pharmacies require patient-specific prescriptions, while 503B facilities can produce medications in bulk without patient-specific prescriptions and are FDA-registered.
Yes, absolutely. It is directly fulfilled by the authorized partners. It may include a 503A or a 503B pharmacy or an authorized wholesaler or a distributor.
Your order has been placed successfully.
We have sent an order confirmation email to
info@example.com